An Alternative HER-2/neu Transcript of 8 kb Has an Extended 3′UTR and Displays Increased Stability in SKOV-3 Ovarian Carcinoma Cells

This publication has 26 references indexed in Scilit:

• HER-2/neu Is Rate-limiting for Ovarian Cancer Growth
  Journal of Biological Chemistry, 1997
• Oncogenic activation of tyrosine kinases
  Current Opinion in Genetics & Development, 1994
• Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.
  Proceedings of the National Academy of Sciences, 1992
• Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
  Science, 1989
• Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene.
  Molecular and Cellular Biology, 1988
• Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.
  Proceedings of the National Academy of Sciences, 1987
• erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 Cells
  Science, 1987
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
  Science, 1987
• Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor
  Nature, 1986
• Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu Oncogene
  Science, 1985